Neil Versel

The companies have expanded their partnership to include GE's Fabric technology as they seek to predict response to metastatic non-small cell lung cancer therapies.

Tempus hopes to get the right patients into genetic sequencing, targeted therapies, and clinical trials with its Edge AI platform and NAPA digital pathology data network.

Genetic oncologist and informatician Olufunmilayo Olopade called for greater diversification of genomic datasets to inform early interventions in high-risk communities.

The bioinformatics firm hopes its AI and "NASA-style" command center will make it easier to get cancer patients into NGS labs and improve trial matching.

Philips has automated the informatics pipeline for NYU Langone's pan-cancer LDT and integrated its Genomics Workspace software with the health system's Epic EMR.

The new partners seek to close the information loop by including providers, payors, and patients in biomarker-guided cancer therapy decisions.

In a keynote to the AMIA Informatics Summit, the NCI director said precision oncology has created new challenges in data analysis and management.

With nearly $100 million in new investments since last year, the San Francisco-based informatics firm looks to ramp up its precision oncology partnerships. 

With $6.5M in new funding, the Israeli bioinformatics startup is looking to open a US office as it builds relationships with pharma, cancer centers, and payors.

Formerly the data analytics division of CTCA, Vidence is supporting an immuno-oncology trial for BMS as it looks to grow its network of hospital partners.